Professor Levinger is an Accredited Exercise Physiologist (AEP) with developed extensive knowledge, skills and experience in the area of bone-muscle interaction, exercise rehabilitation for patients with cardiovascular and metabolic diseases and muscle function in humans and murine models.
Associate Professor Levinger is the Program Director of our Sarcopenia (Clinical) research program.
Sarcopenia, loss of muscle mass and strength, is common in older-adults and it is a major clinical concern in public health globally as it is associated with increased risk of osteoporosis, falls, fractures, disability, impaired capacity to perform activities of daily living and poor quality of life.
The main aim of the Sarcopenia (Clinical) Program is to identify novel pharmacological and non-pharmacological (exercise and diet) interventions to prevent, manage and treat sarcopenia, and its associated comorbidities and improve the quality of life of people with sarcopenia. The program brings together a wide variety of disciplines and expertise including exercise science, physiology, medicine, cardiology and endocrinology.